When examining the similarities between the Phase III trials MAGRIT, START, START2, and TIME, only one tumor antigen was encoded in each vaccine (MAGEA3 for MAGRIT, and MUC1 for START, START2, and TIME) [121,122,141,147,148]. This evidence concerns the gene MAGEA3 and neoplasm.